Tina Tai
Greater China Region Guide 2024
Band 1 : Intellectual Property: Non-litigation (PRC Firms)
Band 1
About
Provided by Tina Tai
Practice Areas
Ms. Tai has more than 27 years' experience as an IP practitioner, and worked with one of China's largest IP firms for long time as the executive member before joining KWM.
Ms. Tai is one of the most influential figures in IP law in the pharmaceutical and healthcare sectors, and has represented many influential cases including the Viagra® (Sildenafil) and Lipitor® (Atrovastatin) for Pfizer, Brillinta® (Ticagrelor) for AstraZeneca, Xarelto® (Rivaroxaban) for Bayer, Actemra® (Tocilizumab) for Roche/Chugai, Victoza® (Liraglutide) for Novo Nordisk, Entresto® (Valsartan Sacubitril) and Revolade® (Eltrombopag) for Novartis, in the patent invalidation and infringement litigations.
Ms. Tai is well experienced with the communication with the courts and government authorities including CNIPA and NMPA for patent and drug regulatory issues.
Chambers Review
Greater China Region
Tina Tai is a market veteran of almost three decades of experience in the IP space. Her expertise in patent invalidation matters is in high demand among pharmaceutical and healthcare companies.
邰红律师是一位在知识产权领域拥有近三十年的经验的资深律师。她在专利无效事宜上的专业知识受到了制药和医疗公司中的热捧。
Strengths
Provided by Chambers
"Tina is very enthusiastic about the industry, not just taking her work as a career but always studying and doing research by herself."
“邰红律师对这个行业充满热情，不仅把工作当成事业，而且自己一直在学习和研究。”
"Tina is very enthusiastic about the industry, not just taking her work as a career but always studying and doing research by herself."
“邰红律师对这个行业充满热情，不仅把工作当成事业，而且自己一直在学习和研究。”
Discover other Lawyers at
King & Wood Mallesons
China
